litlas
ログインアカウント作成

Jianfeng Zhou

1998–2026 年に発表

309
論文数
21,371
被引用数
80
h 指数
265
i10 指数

被引用数

Jianfeng Zhou の年別被引用数1927 年: 被引用 1 件1994 年: 被引用 1 件1995 年: 被引用 1 件1996 年: 被引用 1 件1998 年: 被引用 1 件1999 年: 被引用 4 件2000 年: 被引用 9 件2001 年: 被引用 9 件2002 年: 被引用 12 件2003 年: 被引用 26 件2004 年: 被引用 12 件2005 年: 被引用 18 件2006 年: 被引用 27 件2007 年: 被引用 35 件2008 年: 被引用 30 件2009 年: 被引用 57 件2010 年: 被引用 69 件2011 年: 被引用 71 件2012 年: 被引用 58 件2013 年: 被引用 62 件2014 年: 被引用 47 件2015 年: 被引用 65 件2016 年: 被引用 79 件2017 年: 被引用 79 件2018 年: 被引用 96 件2019 年: 被引用 408 件2020 年: 被引用 728 件2021 年: 被引用 1,080 件2022 年: 被引用 1,135 件2023 年: 被引用 973 件2024 年: 被引用 1,526 件2025 年: 被引用 673 件2026 年: 被引用 65 件1928〜1993 年は被引用が無いため表示していません1997 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図中国: 引用元論文 2,845 件、この内訳の 26.7%アメリカ合衆国: 引用元論文 2,048 件、この内訳の 19.2%ドイツ: 引用元論文 436 件、この内訳の 4.1%イギリス: 引用元論文 430 件、この内訳の 4%イタリア: 引用元論文 394 件、この内訳の 3.7%フランス: 引用元論文 261 件、この内訳の 2.4%オーストラリア: 引用元論文 247 件、この内訳の 2.3%インド: 引用元論文 245 件、この内訳の 2.3%カナダ: 引用元論文 232 件、この内訳の 2.2%スペイン: 引用元論文 230 件、この内訳の 2.2%日本: 引用元論文 211 件、この内訳の 2%オランダ: 引用元論文 187 件、この内訳の 1.8%
0%26.7%その他 27.1%

機関

分野

  • Medicine51.7%
  • Biochemistry, Genetics and Molecular Biology22.4%
  • Immunology and Microbiology4.8%
  • Computer Science3.2%
  • Agricultural and Biological Sciences3.2%
  • Environmental Science2.9%
  • その他11.8%

トピック

  • CAR-T cell therapy research5.2%
  • Lymphoma Diagnosis and Treatment2.5%
  • COVID-19 Clinical Research Studies2.2%
  • Immune Cell Function and Interaction2.2%
  • Cancer Immunotherapy and Biomarkers2.2%
  • Virus-based gene therapy research1.7%
  • その他84%

共著者

全論文

検索で開く
  1. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas

    著者: Xianwen Ren, Wen Wen, Xiaoying Fan, Wenhong Hou, Bin Su, Bin Su, Pengfei Cai, Jiesheng Li, Yang Liu, Fan Zhang, Fan Zhang, Yu Yang, Jiangping He, Wenji Ma, Jingjing He, Pingping Wang, Qiqi Cao, Yuqing Chen, Yuqing Chen, Xuelian Cheng, Xilong Deng, Xilong Deng, Wenyu Ding, Yingmei Feng, Rui Gan, Chuang Guo, Weiqiang Guo, Shuai He, Juanran Liang, Juanran Liang, Jun Lin, Jun Lin, Yun Ling, Jianwei Liu, Jianwei Liu, Nianping Liu, Shu-Qiang Liu, Meng Luo, Qiang Ma, Qibing Song, Wujianan Sun, Feng Wang, Feng Wang, Feng Wang, Ying Wang, Xiaofeng Wen, Qian Wu, Gang Xu, Xudong Xing, Xinxin Xiong, Xudong Xing, Dongdong Yu, Chonghai Yin, Dongdong Yu, Kezhuo Yu, Jin Yuan, Biao Zhang, Peipei Zhang, Tong Zhang, Jincun Zhao, Peidong Zhao, Peidong Zhao, Jianfeng Zhou, Wei Zhou, Sujuan Zhong, Xiaosong Zhong, Shuye Zhang, Jiahua Zou, Ping Zhu, Bin Zou, Jiahua Zou, Zengtao Zuo, Fan Bai, Xi Huang, Penghui Zhou, Qinghua Jiang, Zhiwei Huang, Jin‐Xin Bei, Lai Wei, Xiu‐Wu Bian, Xindong Liu, Tao Cheng, Xiangpan Li, Pingsen Zhao, Pingsen Zhao, Fu‐Sheng Wang, Xiaoqun Wang, Hongyang Wang, Bing Su, Bing Su, Zheng Zhang, Kun Qu, Xiaoqun Wang, Jiekai Chen, Ronghua Jin, Zemin Zhang - Cell 2021 被引用: 947

  2. Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer

    著者: Jin Li, Shukui Qin, Rui‐Hua Xu, Lin Shen, Jianming Xu, Yuxian Bai, Lei Yang, Yanhong Deng, Zhen-dong Chen, Haijun Zhong, Hongming Pan, Weijian Guo, Yongqian Shu, Ying Yuan, Jianfeng Zhou, Nong Xu, Tianshu Liu, Dong Ma, Changping Wu, Ying Cheng, Donghui Chen, Wei Li, Sanyuan Sun, Zhuang Yu, Peiguo Cao, Haihui Chen, Jiejun Wang, Shubin Wang, Hongbing Wang, Songhua Fan, Hua Ye, Weiguo Su - JAMA 2018 被引用: 404

  3. A phase 1 study of a novel fully human BCMA-targeting CAR (CT103A) in patients with relapsed/refractory multiple myeloma

    著者: Di Wang, Jue Wang, Jue Wang, Guang Hu, Wen Wang, Yi Xiao, Haodong Cai, Lijun Jiang, Meng Li, Yongkun Yang, Xiaoxi Zhou, Zhenya Hong, Zheng Yao, Min Xiao, Liting Chen, Xia Mao, Li Zhu, Jin Wang, Jin Wang, Lugui Qiu, Chunrui Li, Jianfeng Zhou - Blood 2021 被引用: 210

  4. Advances in Universal CAR-T Cell Therapy

    著者: Haolong Lin, Jiali Cheng, Wei Mu, Jianfeng Zhou, Li Zhu - Frontiers in Immunology 2021 被引用: 198

  5. Engineering-enhanced CAR T cells for improved cancer therapy

    著者: Michael C. Milone, Jie Xu, Sai‐Juan Chen, McKensie Collins, Jianfeng Zhou, Daniel J. Powell, J. Joseph Melenhorst - Nature Cancer 2021 被引用: 134

  6. Elaiophylin triggers paraptosis and preferentially kills ovarian cancer drug-resistant cells by inducing MAPK hyperactivation

    著者: Guannan Li, Xuejiao Zhao, Zhen Wang, Meng-Shi Luo, Shen-Nan Shi, Danmei Yan, Huayi Li, Jiahao Liu, Yang Yang, Jiahong Tan, Zeyu Zhang, Ru-Qi Chen, Hui‐Ling Lai, Xiaoyuan Huang, Jianfeng Zhou, Ding Ma, Yong Fang, Qinglei Gao - Signal Transduction and Targeted Therapy 2022 被引用: 101

  7. Genome-wide profiling of HPV integration in cervical cancer identifies clustered genomic hot spots and a potential microhomology-mediated integration mechanism

    著者: Zheng Hu, Da Zhu, Wei Wang, Weiyang Li, Wenlong Jia, Xi Zeng, Wencheng Ding, Lan Yu, Xiaoli Wang, Liming Wang, Hui Shen, Changlin Zhang, Hongjie Liu, Xiao Liu, Yi Zhao, Xiaodong Fang, Shuai Cheng Li, Wei Chen, Tang Tang, Aisi Fu, Zou Wang, Gang Chen, Qinglei Gao, Shuang Li, Ling Xi, Changyu Wang, Shujie Liao, Xiangyi Ma, Peng Wu, Kezhen Li, Shixuan Wang, Jianfeng Zhou, Jun Wang, Xun Xu, Hui Wang, Ding Ma - Nature Genetics 2015 被引用: 624

  8. PD-1 expression and clinical PD-1 blockade in B-cell lymphomas

    著者: Zijun Y. Xu‐Monette, Jianfeng Zhou, Ken H. Young - Blood 2017 被引用: 430

  9. Efficacy and safety of CAR19/22 T-cell cocktail therapy in patients with refractory/relapsed B-cell malignancies

    著者: Na Wang, Xuelian Hu, Wenyue Cao, Chunrui Li, Yi Xiao, Yang Cao, Chaojiang Gu, Shangkun Zhang, Liting Chen, Jiali Cheng, Gaoxiang Wang, Xiaoxi Zhou, Miao Zheng, Xia Mao, Lijun Jiang, Di Wang, Qiuxiang Wang, Yaoyao Lou, Haodong Cai, Dandan Yan, Yicheng Zhang, Tongcun Zhang, Jianfeng Zhou, Liang Huang - Blood 2019 被引用: 264

  10. Current Status and Perspectives of Dual-Targeting Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Hematological Malignancies

    著者: Bailu Xie, Zhengdong Li, Jianfeng Zhou, Wen Wang - Cancers 2022 被引用: 84

  11. Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China

    著者: Yuankai Shi, Bo Jia, Wei Xu, Wenyu Li, Ting Liu, Peng Liu, Weili Zhao, Huilai Zhang, Xiuhua Sun, Haiyan Yang, Xi Zhang, Jie Jin, Zhengming Jin, Zhiming Li, Lugui Qiu, Mei Dong, Xiaobing Huang, Yi Luo, Xiaodong Wang, Xin Wang, Jianqiu Wu, Jingyan Xu, Pingyong Yi, Jianfeng Zhou, Hongming He, Lin Liu, Jianzhen Shen, Xiaoqiong Tang, Jinghua Wang, Jianmin Yang, Qingshu Zeng, Zhihui Zhang, Zhen Cai, Xiequn Chen, Kaiyang Ding, Ming Hou, Huiqiang Huang, Xiaoling Li, Rong Liang, Qifa Liu, Yuqin Song, Hang Su, Yuhuan Gao, Lihong Liu, Jian‐Min Luo, Liping Su, Zimin Sun, Huo Tan, Huaqing Wang, Jingwen Wang, Shuye Wang, Hongyu Zhang, Xiaohong Zhang, Daobin Zhou, Ou Bai, Gang Wu, Liling Zhang, Yizhuo Zhang - Journal of Hematology & Oncology 2017 被引用: 256

  12. Development and validation of a prediction rule for estimating gastric cancer risk in the Chinese high-risk population: a nationwide multicentre study

    著者: Quan-cai Cai, Chunping Zhu, Yuan Yuan, Qi Feng, Yi-Chao Feng, Ying-Xia Hao, Jichang Li, Kaiguang Zhang, Guoliang Ye, Liping Ye, Nonghua Lv, Shengsheng Zhang, Chengxia Liu, Mingquan Li, Qi Liu, Rongzhou Li, Jie Pan, Xiaocui Yang, Xuqing Zhu, Yumei Li, Bo Lao, Ansheng Ling, Honghui Chen, Xiuling Li, Ping Xu, Jianfeng Zhou, Baozhen Liu, Zhi‐qiang Du, Yiqi Du, Zhaoshen Li - Gut 2019 被引用: 223

  13. Tropism-facilitated delivery of CRISPR/Cas9 system with chimeric antigen receptor-extracellular vesicles against B-cell malignancies

    著者: Qian Xu, Zheng Zhang, Lei Zhao, Yun Qin, Haodong Cai, Zhe Geng, Xiaojian Zhu, Wei Zhang, Yuanyuan Zhang, Jiaqi Tan, Jue Wang, Jianfeng Zhou - Journal of Controlled Release 2020 被引用: 99

  14. T cells expressing CD5/CD7 bispecific chimeric antigen receptors with fully human heavy-chain-only domains mitigate tumor antigen escape

    著者: Zhenyu Dai, Wei Mu, Ya Zhao, Jiali Cheng, Haolong Lin, Kedong Ouyang, Xiangyin Jia, Jianwei Liu, Qiaoe Wei, Meng Wang, Chaohong Liu, Taochao Tan, Jianfeng Zhou - Signal Transduction and Targeted Therapy 2022 被引用: 82

  15. Heterotypic CAF-tumor spheroids promote early peritoneal metastasis of ovarian cancer

    著者: Qinglei Gao, Zongyuan Yang, Sen Xu, Xiaoting Li, Xin Yang, Ping Jin, Yi Liu, Xiaoshui Zhou, Taoran Zhang, Cheng Gong, Wei Xiao, Dan Liu, Chaoyang Sun, Gang Chen, Junbo Hu, Meng Li, Jianfeng Zhou, Kenjiro Sawada, Robert Fruscio, Thomas W. Grunt, Jörg Wischhusen, Víctor Manuel Vargas-Hernández, Bhavana Pothuri, Robert L. Coleman - The Journal of Experimental Medicine 2019 被引用: 258

  16. The prognostic value of sarcopenia in oesophageal cancer: A systematic review and meta‐analysis

    著者: Pinhao Fang, Jianfeng Zhou, Xin Xiao, Yu‐Shang Yang, Siyuan Luan, Zhiwen Liang, Xiaokun Li, Hanlu Zhang, Qixin Shang, Xiaoxi Zeng, Yong Yuan - Journal of Cachexia Sarcopenia and Muscle 2022 被引用: 123

  17. Humoral immune reconstitution after anti-BCMA CAR T-cell therapy in relapsed/refractory multiple myeloma

    著者: Ying Wang, Chunrui Li, Jieyun Xia, Ping Li, Jiang Cao, Bin Pan, Xu Tan, Hujun Li, Kunming Qi, Xiangmin Wang, Ming Shi, Guangjun Jing, Zhiling Yan, Hai Cheng, Feng Zhu, Haiying Sun, Wei Sang, Depeng Li, Xi Zhang, Zhenyu Li, Junnian Zheng, Aibin Liang, Jianfeng Zhou, Kailin Xu - Blood Advances 2021 被引用: 102

  18. Zanubrutinib in relapsed/refractory mantle cell lymphoma: long-term efficacy and safety results from a phase 2 study

    著者: Yuqin Song, Keshu Zhou, Dehui Zou, Jianfeng Zhou, Jianda Hu, Haiyan Yang, Huilai Zhang, Jie Ji, Wei Xu, Jie Jin, Fangfang Lv, Ru Feng, Sujun Gao, Haiyi Guo, Lei Zhou, Jane Huang, William Novotny, Pil Kim, Yiling Yu, Binghao Wu, Jun Zhu - Blood 2022 被引用: 169

  19. The rational development of CD5-targeting biepitopic CARs with fully human heavy-chain-only antigen recognition domains

    著者: Zhenyu Dai, Wei Mu, Ya Zhao, Xiangyin Jia, Jianwei Liu, Qiaoe Wei, Taochao Tan, Jianfeng Zhou - Molecular Therapy 2021 被引用: 62

  20. Simulating urban land use change by integrating a convolutional neural network with vector-based cellular automata

    著者: Yaqian Zhai, Yao Yao, Qingfeng Guan, Xun Liang, Xia Li, Yongting Pan, Hanqiu Yue, Zehao Yuan, Jianfeng Zhou - International Journal of Geographical Information Systems, Int. J. Geogr. Inf. Sci. 2020 被引用: 140

  21. Airborne pathogenic microorganisms and air cleaning technology development: A review

    著者: Lu Song, Jianfeng Zhou, Can Wang, Meng Ge, Yunfei Li, Mourin Jarin, Ziyan Wu, Xing Xie - Journal of Hazardous Materials 2021 被引用: 132

  22. The development and progress of nanomedicine for esophageal cancer diagnosis and treatment

    著者: Xiaokun Li, Lingmin Chen, Siyuan Luan, Jianfeng Zhou, Xin Xiao, Yu‐Shang Yang, Chengyi Mao, Pinhao Fang, Long-Qi Chen, Xiaoxi Zeng, Huile Gao, Yong Yuan - Seminars in Cancer Biology 2022 被引用: 98

  23. Efficacy and safety of CD19-specific CAR T cell–based therapy in B-cell acute lymphoblastic leukemia patients with CNSL

    著者: Yuekun Qi, Mingfeng Zhao, Yongxian Hu, Ying Wang, Ping Li, Jiang Cao, Ming Shi, Jiaqi Tan, Meng Zhang, Xia Xiao, Jieyun Xia, Sha Ma, Jianlin Qiao, Zhiling Yan, Hujun Li, Bin Pan, Wei Sang, Depeng Li, Zhenyu Li, Jianfeng Zhou, He Huang, Aibin Liang, Junnian Zheng, Kailin Xu - Blood 2022 被引用: 98

  24. UAV Swarms in Smart Agriculture: Experiences and Opportunities

    著者: Chengyi Qu, Jayson Boubin, Durbek Gafurov, Jianfeng Zhou, Noel Aloysius, Henry Nguyen, Prasad Calyam - IEEE 18th International Conference on e-Science (e-Science) 2022 被引用: 46